Table 1.
Baseline characteristics of the subjects who completed the intervention trial 1.
| Characteristics | Placebo (n = 42) | MP (n = 38) | P-Value 2 |
|---|---|---|---|
| Age (year) | 44 ± 2 3 | 43 ± 2 | 0.918 |
| Female/Male (n) | 23/19 | 19/19 | 0.670 |
| Body mass index (kg/m2) | 24 ± 0.4 | 24 ± 0.5 | 0.918 |
| Systolic blood pressure (mmHg) | 122 ± 3 | 119 ± 2 | 0.474 |
| Diastolic blood pressure (mmHg) | 82 ± 3 | 78 ± 2 | 0.329 |
| Serum triglycerides (mg/dL) | 108 ± 8 | 141 ± 15 | 0.060 |
| Serum total cholesterol (mg/dL) | 180 ± 5 | 187 ± 4 | 0.226 |
| Serum HDL-cholesterol (mg/dL) | 55 ± 2 | 54 ± 3 | 0.534 |
| Serum LDL-cholesterol (mg/dL) | 102 ± 5 | 104 ± 4 | 0.694 |
| Smoker/Non-smoker 3 | 8/34 | 7/31 | 0.076 |
1 Data are the means ± SE (all such values). MP, multi-micronutrient supplement with nutritional doses of antioxidant nutrients and plant ingredients; 2 The Student’s t-test or chi-square test (gender and smoking) was used to compare differences between groups; 3 Smokers were defined as subjects who used to smoke more than three cigarettes per day.